Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	39	non-cytoplasmic
40	60	transmembrane
61	93	cytoplasmic
94	117	transmembrane
118	124	non-cytoplasmic
125	144	transmembrane
145	151	cytoplasmic
152	176	transmembrane
177	202	non-cytoplasmic
203	222	transmembrane
223	233	cytoplasmic
234	256	transmembrane
257	279	non-cytoplasmic
280	310	transmembrane
311	330	cytoplasmic
331	352	transmembrane
353	357	non-cytoplasmic
358	382	transmembrane
383	396	cytoplasmic
397	413	transmembrane
414	418	non-cytoplasmic
419	438	transmembrane
439	450	cytoplasmic
451	469	transmembrane
470	475	non-cytoplasmic

Input:
>Pf1N1B4_614
MSESPGKLKLGALVALVVGSMIGGGIFSLPQNMAASADVGAVLIGWAITAVGMLTLAFVF
QTLANRKPDLDGGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFFPVF
GEGNTVAAVIGASLLLWGVHFLVLRGIKEAAFINLVTTVAKIVPLLLFVLIAIFAFKLEI
FTADIWGLKNPDLGSVMNQVRKMMLVTVWVFIGIEGASIFSARAEKRSDVGKATVIGFIT
VLLFLVLVNVLSLGIMTQPELAKLQNPSMAAVLEHVVGHWGAVLISVGLIISLLGALLSW
VLLCAEIMFAAAKDHTMPAFLRRENANHVPVNALWLTNAMVQLFLIITLFSASTYLSLIY
LATSMILVPYLWSAAYALLLAVRGESYENAAAERRKDLFIGAVALTYAVWLIYAGGVKYL
LLSALLYAPGAILFAKAKLEVNKSVFTNVEKLIFAAVVVGALVAAYGLYDGFLTL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server